Skip to content
DefDex

Federal award

QUALTEX LABORATORIES

W91YTZ21C0006

Contract

Obligated and Ceiling

Obligated (net)
$3,948,537.18
Ceiling (potential value, not spending)
$3,948,537.18
Current value
$3,948,537.18
Gross positive obligations
$6,370,329.02

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
QUALTEX LABORATORIES · G3PLDLPUHU13
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
QUALTEX LABORATORIES · G3PLDLPUHU13
Awarding agency
Department of War · sub-agency 2100 · office W91YTZ
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W91YTZ21C0006
Award type code
D
Actions
17 · Mar 31, 2021 to Jul 8, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History17

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 8, 2025FY2025P00017C−$99,999.21
—
Mar 26, 2025FY2025P00016C−$349,999.40
—
Feb 14, 2025FY2025P00015C−$286,153.39
—
Oct 31, 2024FY2025P00014C$1,340,232.25
—
Jul 24, 2024FY2024P00013G$0.00
—
Jul 23, 2024FY2024P00012C−$674,547.66
—
Nov 17, 2023FY2024P00011C$1,307,590.85
—
Sep 22, 2023FY2023P00010C−$100,000.00
—
Sep 14, 2023FY2023P00008G$0.00
—
Dec 5, 2022FY2023P00007C$0.00
—
Nov 9, 2022FY2023P00006C$1,275,662.86
—
Jun 15, 2022FY2022P00005G$0.00
—
Mar 22, 2022FY2022P00004C−$661,092.18
—
Mar 4, 2022FY2022P00003C−$250,000.00
—
Oct 7, 2021FY2022P00002C$1,238,507.11
—
Jun 17, 2021FY2021P00001G$0.00
—
Mar 31, 2021FY20210—$1,208,335.95
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.